Clinical Trial Update: BIIR Gene to Manage Heart Allograft Patients

View source ↗

Summary

A Baylor Research Institute trial evaluating BIIR gene therapy for heart transplant failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplant Failure

Drugs mentioned

• BIIR gene therapy (BIIR gene therapy)

Snippet

Sponsor: Baylor Research Institute | Conditions: Cardiac Transplant Failure | Status: COMPLETED